EU Novel Food Regulations for Mushroom Supplements: What Supplement Brands Need to Know

Introduction

The European functional mushroom market is growing fast. Brands across Scandinavia, the Netherlands, Germany, and beyond are adding Lion’s Mane capsules, Reishi tinctures, and Cordyceps powders to their product lines — only to discover, sometimes mid-launch, that their chosen mushroom ingredient may require regulatory authorisation they do not have.

EU Novel Food regulation is not new, but its application to mushroom-based supplements has become significantly more scrutinised since 2022. For B2B supplement brands sourcing ingredients in bulk, understanding which species are compliant, which require formal authorisation, and what documentation to demand from your supplier is no longer optional. Getting it wrong risks product recalls, fines, and reputational damage across multiple EU jurisdictions.

This guide breaks down exactly where the lines fall, what the authorisation process involves, how UK rules diverge post-Brexit, and what practical steps your brand should take right now.

What Is EU Novel Food Regulation?

EU Novel Food Regulation — formally Regulation (EU) 2015/2283, which came into force on 1 January 2018 — governs food and food ingredients that were not consumed to a significant degree within the European Union before 15 May 1997. That date is the legal dividing line. If a food ingredient was not widely eaten in the EU before that date, it is classified as “novel”. It cannot be marketed without prior authorisation from the European Commission, based on a safety assessment conducted by the European Food Safety Authority (EFSA).

The regulation replaced the earlier Novel Food framework (Regulation (EC) 258/97) and introduced a centralised authorisation procedure managed through EFSA. It also created two distinct pathways: standard authorisation (for genuinely new ingredients) and a simplified notification procedure for traditional foods from third countries with a history of safe use outside the EU.

For mushroom supplements, the regulatory landscape is a complex patchwork. The mushroom itself may have a history of culinary use in Europe. Still, a concentrated extract — produced by ethanol, hot water, or supercritical CO₂ extraction — may constitute a different ingredient with a different regulatory status. The form, concentration, intended use, and method of preparation all affect whether the Novel Food classification applies.

The European Commission maintains a Novel Food Catalogue — a non-legally binding but practically essential reference that lists the status of ingredients as assessed by member state competent authorities. Brands and their legal teams routinely consult this catalogue, though entries can be disputed and member-state interpretations can vary.

Which Mushroom Species Are Classified as Novel Food in the EU?

Not all mushrooms are treated equally under EU law. The key distinction is between species with a well-documented history of food consumption in Europe before May 1997, and those — particularly functional or medicinal mushrooms — that were primarily consumed in Asia and entered European commerce more recently.

Mushrooms That Are Classified as Novel Food

The following species, particularly in extract or concentrated supplement form, are widely regarded as Novel Food in the EU or fall into a contested grey area requiring careful legal review before market entry:

• Cordyceps militaris — Listed in the EU Novel Food Catalogue as novel. There is no significant pre-1997 consumption history in Europe for this species. Cordyceps sinensis (the caterpillar fungus) is similarly positioned. Any Cordyceps extract, powder, or capsule product intended for the EU market requires Novel Food authorisation or must rely on a demonstrable traditional food notification pathway.
• Ganoderma lucidum (Reishi) — This is one of the most commercially significant grey-area species. Whole dried Reishi mushrooms have a history of use in certain EU markets. Still, concentrated extracts (particularly standardised polysaccharide or triterpene extracts sold in capsule or tincture form) are considered by several member state authorities to constitute a novel ingredient not covered by any pre-1997 consumption history. Brands marketing high-potency Reishi extracts in Germany, France, and Scandinavia have faced enforcement action.
• Hericium erinaceus (Lion’s Mane) — This species has a particularly complex status. It appears in the Novel Food Catalogue as having been assessed. Some member states (notably the Netherlands and certain Nordic regulators) have adopted a more permissive stance where the mushroom itself (not concentrated extract) has been allowed on the market, while others take a stricter line. As of 2025, there is no harmonised, EU-wide Novel Food authorisation for Lion’s Mane. Brands should seek country-specific legal advice before launch.
• Tremella fuciformis (Snow fungus / Silver ear mushroom) — Generally considered novel in the EU supplement context, though it has traditional culinary use in Asian communities resident in Europe, which creates some ambiguity.
• Inonotus obliquus (Chaga) — Treated as Novel Food in most EU jurisdictions. The EU Novel Food Catalogue flags Chaga as having, to a significant degree, insufficient evidence of pre-1997 consumption in the EU.

Mushrooms with an Established History of Consumption (Generally Exempt)

Several mushroom species had a long, well-documented history of consumption as food in Europe before May 1997. They are generally not subject to Novel Food requirements when used in their conventional food forms:

• Agaricus bisporus (White button mushroom / Portobello) — By far the most widely consumed mushroom in Europe. Clearly exempt.
• Pleurotus ostreatus (Oyster mushroom) — Commercially cultivated and consumed in Europe for decades before 1997. Generally exempt, though concentrated extracts may attract scrutiny.
• Lentinula edodes (Shiitake) — Well-established in European food markets before 1997, particularly through Asian food retail. Generally exempt in food form. High-concentration shiitake polysaccharide extracts may require separate assessment.
• Auricularia auricula-judae (Wood ear / Black fungus) — Has a documented history of sale and consumption in European Asian grocery markets before 1997. Generally considered exempt, though some authorities have raised questions about specific extract forms.

Novel Food Status Comparison Table

The Key Test: Traditional Use Before May 1997

The central question in any Novel Food assessment is deceptively simple: was this ingredient consumed to a significant degree within the EU before 15 May 1997? In practice, answering this question requires documentary evidence — sales records, historical food surveys, academic literature, archival trade data — and the burden of proof lies with the operator placing the food in the market.

“Significant degree” has no precise legal definition. Still, EFSA guidance indicates that it implies a meaningful proportion of the population consuming the ingredient regularly over time, rather than isolated or niche use. A product sold in a small number of Asian speciality shops in one member state in 1996 is unlikely to meet this threshold across all 27 member states.

There is also an important distinction between traditional food use and novel food status. A mushroom might have been eaten as food in China for centuries. Still, if it was not part of the EU food supply before May 1997, its traditional use elsewhere does not automatically exempt it from the requirement. However, under Article 14 of Regulation (EU) 2015/2283, operators can apply for authorisation of traditional foods from third countries through a simplified notification procedure, in which the safety history in the country of origin is the primary evidence base — provided that member states, or EFSA, raise no safety objections.

For supplement brands, the practical implication is this: your legal position depends not just on the species name, but on the form (dried whole mushroom vs extract), the concentration (standardised to specific compounds), and the intended use category (food supplement vs food ingredient vs food special purposes). A 1:1 mushroom powder in a food context may be treated very differently from a 10:1 extract standardised to 30% beta-glucans in a capsule.

What Happens If Your Extract Is Classified as Novel Food?

If your mushroom ingredient falls within the Novel Food classification and no current authorisation covers it, marketing it as a food supplement in the EU is unlawful. The consequences range from informal warnings and product removal requests from national competent s  authorities to formal enforcement actions including recalls, fines, dand in   some jurisdictions potential criminal liability for company directors.

The route to legal market access is Novel Food authorisation via EFSA. The process works as follows:

1. Pre-submission consultation — EFSA and the European Commission offer informal pre-submission advice. This stage helps applicants understand what safety data will be required.
2. Formal application submission — Applications are submitted through the EFSA submission portal and must include a comprehensive dossier covering: identity and specification of the ingredient, production process, compositional data, stability data, proposed use levels and conditions, nutritional information, and a toxicological safety assessment (including genotoxicity, subchronic and chronic toxicity data, and where applicable, human safety data).
3. EFSA scientific opinion — EFSA has nine months from validation to deliver its opinion, though this timeline is regularly extended in practice. Complex dossiers routinely take 18–36 months at this stage alone.
4. Commission authorisation decision — Following a positive EFSA opinion, the European Commission prepares an implementing regulation authorising the Novel Food. This adds further months to the process.

Total timeline from application to authorisation: typically 3 to 5 years, with some cases taking longer. Total cost for a standalone applicant: €300,000 to €1,000,000+ depending on the toxicological data requirements and whether existing published studies are sufficient or new animal or human studies are required.

One important commercial consideration is data protection. Under Regulation (EU) 2015/2283, the first authorisation holder for a novel food ingredient receives five years of data protection — meaning competitors cannot rely on the original applicant’s safety dossier during that period. This creates an incentive for individual authorisation, though consortium applications (where multiple companies share costs) are also possible and increasingly common for ingredients with broad industry interest.

For brands unable to wait for full authorisation, the only compliant route is to restrict sales to markets where the ingredient has country-specific clearance (with appropriate legal advice for each jurisdiction) or to reformulate using authorised ingredients.

UK vs EU Novel Food Rules Post-Brexit

Since the UK left the EU on 31 January 2020, and the transition period ended on 31 December 2020, Great Britain (England, Wales, Scotland) operates its own Novel Food regime under the retained UK Novel Food Regulation (Regulation (EC) 258/97 as retained and amended), administered by the Food Standards Agency (FSA). Northern Ireland continues to follow EU rules under the Windsor Framework.

The practical divergence is significant for mushroom supplement brands:

• The UK Novel Food List, maintained by the FSA, reflects the state of EU Novel Food decisions as of the end of the transition period and has been updated independently since then. An ingredient authorised in the EU after 31 December 202020 is not automatically authorised in Great Britain — a separate UK application or GB-specific decision is required.
• The FSA has taken a notably different approach to some functional mushrooms. Lion’s Mane (Hericium erinaceus), for example, was placed on the FSA’s Novel Food list, meaning it cannot legally be sold as a food supplement in Great Britain without authorisation — despite being tolerated in several EU member states. This is a case where EU rules are, in practice, more permissive than UK rules.
• Cordyceps and Reishi extracts are classified as Novel Food in both the UK and EU, creating consistent compliance obligations across both markets.
• Brands selling into both the EU and UK must maintain separate compliance files for each jurisdiction and should not assume that legal clearance in one market transfers to the other.

The FSA has committed to reviewing its Novel Food list and is conducting ongoing consultations on several functional ingredients, including some mushroom species. Brands should monitor FSA updates regularly and engage with industry associations that participate in consultation processes.

Practical Steps for Supplement Brands Sourcing Mushroom Extracts in 2025

For B2B supplement brands operating in or exporting to the EU, the following steps represent current best practice for Novel Food compliance when sourcing functional mushroom extracts:

1. Map your target markets before selecting your ingredient. Novel Food enforcement varies significantly between member states. Germany, France, and the Nordic countries have historically been among the strictest enforcers. If your primary markets are in these jurisdictions, your compliance obligations are highest, and your ingredient selection must be most conservative.
2. Check the EU Novel Food Catalogue for every species and form you intend to use. The catalogue is available on the European Commission website. Check not just the species, but the specific form (extract, powder, dried whole mushroom) and the intended application (food supplementvs. food ingredient).
3. Request a formal regulatory opinion from a food law specialist for grey-area species. For Lion’s Mane, Reishi extracts, and Tremella, a written legal opinion from a specialist EU food law firm is money well spent before committing to product development.
4. Demand full documentation from your extract supplier. This is non-negotiable. Your supplier should be able to provide: species identification documentation, production process description, compositional analysis, and either a clear Novel Food Catalogue reference confirming exempt status, or evidence of a pending or granted EFSA authorisation.
5. Implement a product-level compliance file. For each product containing a mushroom extract, maintain a compliance file that includes the supplier’s documentation, your legal opinion (if obtained), and your own assessment of Novel Food status. This file should be available for inspection by national competent authorities.
6. Review labelling against EU food supplement regulations. Separate from Novel Food rules, mushroom supplement labelling must comply with Regulation (EU) 1169/2011 (food information to consumers), and any health claims must be authorised under Regulation (EC) 1924/2006. Most functional claims for mushroom extracts are not on the EU positive list.

How to Verify Your Supplier’s Compliance

The quality of your compliance position is only as good as the documentation your supplier can provide. When evaluating a mushroom extract supplier for the EU market, the following documentation requests are essential:

Documentation Checklist for EU-Compliant Mushroom Extract Sourcing

• Species identification and authentication — Certificate of analysis confirming species identity via DNA barcoding or microscopic analysis, not just visual inspection.
• Novel Food status statement — A written statement from the supplier’s regulatory team referencing the specific EU Novel Food Catalogue entry for the ingredient, or confirming the basis on which it is considered exempt (with citations to historical use evidence).
• EFSA authorisation reference (if applicable) — If the ingredient is an authorised Novel Food, the authorisation implementing regulation reference number and the specific use conditions under which it is authorised.
• Country-specific clearance letters — For grey-area species, evidence that the ingredient has been specifically assessed and cleared by the relevant national competent authority in your target market(s).
• Production process documentation — Extraction method, solvent used (if any), concentration ratios, and standardisation parameters. This matters because the regulatory status may differ between a 1:1 dried powder and a 10:1 ethanol extract.
• Certificate of analysis (CoA) — Batch-specific CoA confirming active compound content, heavy metal levels, microbiological status, and absence of pesticide residues at levels exceeding EU MRLs.
• Allergen and contaminant declarations — Confirmation of the absence of relevant contaminants including mycotoxins and polycyclic aromatic hydrocarbons (PAHs), which have been detected in some Chaga preparations.

At FunctionalMushrooms.eu, we supply all of the above documentation as standard for every B2B customer. Our compliance team can also provide regulatory briefings on the current Novel Food status of each species in our catalogue, tailored to your target markets. We understand that compliance is not a checkbox — it is a continuous process that requires up-to-date regulatory intelligence and a supplier who is invested in your success.

If you need support reviewing your current product line or planning a compliant launch in new EU markets, contact us to speak with our regulatory team.

FAQ: EU Novel Food Regulations and Mushroom Supplements

Is Lion’s Mane mushroom a Novel Food in the EU?

Lion’s Mane (Hericium erinaceus) has no harmonised EU-wide Novel Food authorisation as of 2025. Some member states tolerate it on the market; others do not. Brands must obtain country-specific legal advice before marketing Lion’s Mane supplements in the EU. In the UK, it is formally classified as Novel Food by the FSA.

Do EU Novel Food regulations apply to mushroom powders as well as extracts?

Yes, Novel Food regulations can apply to both. However, a simple dried and ground whole mushroom is more likely to be considered as having traditional food use than a concentrated extract. The form, concentration, and production process all affect regulatory classification. Always verify the specific form you intend to use.

How long does Novel Food authorisation take in the EU?

A full Novel Food authorisation via EFSA typically takes between 3 and 5 years from application to final Commission implementing regulation. The process includes EFSA’s scientific opinion (a minimum of 9 months, often longer) and the Commission’s authorisation decision. Costs typically range from €300,000 to over €1,000,000 depending on data requirements.

Can I sell mushroom supplements in the EU while Novel Food authorisation is pending?

No. A pending application does not grant any right to market an unauthorised Novel Food ingredient. You may only sell a novel food supplement in the EU if it has a valid authorisation, or if you can demonstrate it is not novel (i.e., pre-1997 EU consumption history). Country-specific toleration does not constitute EU-wide legal clearance.

What is the difference between EU and UK Novel Food regulations for mushrooms?

The EU and UK operate separate Novel Food regimes since Brexit. The UK FSA maintains its own list and has classified some species — including Lion’s Mane — as Novel Food even where certain EU member states tolerate it. An EU Novel Food authorisation granted after December 2020 does not automatically apply in Great Britain. Separate compliance is required for each market.

Conclusion

EU Novel Food regulation is one of the most significant compliance challenges facing supplement brands in the functional mushroom space today. With enforcement increasing across key EU markets and the UK operating its own parallel regime, the days of treating these regulations as theoretical are over.

The core message is straightforward: if you are sourcing mushroom extracts for the EU supplement market, you need clarity on the Novel Food status of every ingredient in every form you intend to sell, in every market you intend to sell it. That clarity starts with your supplier.

FunctionalMushrooms.eu is a B2B wholesale supplier of certified mushroom extracts with full compliance documentation, including Novel Food status assessments, CoAs, species authentication, and regulatory support for EU and UK markets. Our functional mushroom extracts are supplied with complete regulatory transparency so your brand can launch with confidence.

Ready to discuss your compliance requirements? Contact us to speak with our team about sourcing compliant mushroom extracts for your product line.

Find a Supplier in Your Country

We supply mushroom extracts across Europe with full regulatory documentation:

• Lion’s Mane Supplier Germany
• Lion’s Mane Supplier Netherlands
• Lion’s Mane Supplier UK
• Reishi Supplier Germany
• Cordyceps Supplier Germany